Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Wiley Interdisciplinary Reviews. Developmental Biology
|
November 18, 2014
RNAi in the mouse: rapid and affordable gene function studies in a vertebrate system
Julie A Rytlewski, Slobodan Beronja
Microvascular Research
|
February 26, 2015
Mechanisms of tubulogenesis and endothelial phenotype expression by MSCs
Julie A Rytlewski, M Alejandra Aldon, Evan W Lewis, et al.
Oncoimmunology
|
October 25, 2019
The impact of CTLA-4 blockade and interferon-α on clonality of T-cell repertoire in the tumor microenvironment and peripheral blood of metastatic melanoma patients
Arjun Khunger, Julie A Rytlewski, Paul Fields, et al.
Tissue Engineering. Part C, Methods
|
January 10, 2012
Three-dimensional image quantification as a new morphometry method for tissue engineering
Julie A Rytlewski, Laura R Geuss, Chinedu I Anyaeji, et al.
Acta Biomaterialia
|
January 21, 2015
Fibrin-based 3D matrices induce angiogenic behavior of adipose-derived stem cells
Eunna Chung, Julie A Rytlewski, Arjun G Merchant, et al.
Plos One
|
August 30, 2021
Impact of HLA type, age and chronic viral infection on peripheral T-cell receptor sharing between unrelated individuals
Sarah A Johnson, Spencer L Seale, Rachel M Gittelman, et al.
Cell Stem Cell
|
November 4, 2017
TGF-β-Induced Quiescence Mediates Chemoresistance of Tumor-Propagating Cells in Squamous Cell Carcinoma
Jessie A Brown, Yoshiya Yonekubo, Nicole Hanson, et al.
JCI Insight
|
July 13, 2018
T cell receptor repertoire features associated with survival in immunotherapy-treated pancreatic ductal adenocarcinoma
Alexander C Hopkins, Mark Yarchoan, Jennifer N Durham, et al.
Journal for Immunotherapy of Cancer
|
October 2, 2020
CDK4/6 inhibition enhances antitumor efficacy of chemotherapy and immune checkpoint inhibitor combinations in preclinical models and enhances T-cell activation in patients with SCLC receiving chemotherapy
Anne Y Lai, Jessica A Sorrentino, Konstantin H Dragnev, et al.
Journal for Immunotherapy of Cancer
|
October 25, 2018
Neoadjuvant ipilimumab (3 mg/kg or 10 mg/kg) and high dose IFN-α2b in locally/regionally advanced melanoma: safety, efficacy and impact on T-cell repertoire
Ahmad Tarhini, Yan Lin, Huang Lin, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Wiley Interdisciplinary Reviews. Developmental Biology
|
November 18, 2014
RNAi in the mouse: rapid and affordable gene function studies in a vertebrate system
Julie A Rytlewski, Slobodan Beronja
Microvascular Research
|
February 26, 2015
Mechanisms of tubulogenesis and endothelial phenotype expression by MSCs
Julie A Rytlewski, M Alejandra Aldon, Evan W Lewis, et al.
Oncoimmunology
|
October 25, 2019
The impact of CTLA-4 blockade and interferon-α on clonality of T-cell repertoire in the tumor microenvironment and peripheral blood of metastatic melanoma patients
Arjun Khunger, Julie A Rytlewski, Paul Fields, et al.
Tissue Engineering. Part C, Methods
|
January 10, 2012
Three-dimensional image quantification as a new morphometry method for tissue engineering
Julie A Rytlewski, Laura R Geuss, Chinedu I Anyaeji, et al.
Acta Biomaterialia
|
January 21, 2015
Fibrin-based 3D matrices induce angiogenic behavior of adipose-derived stem cells
Eunna Chung, Julie A Rytlewski, Arjun G Merchant, et al.
Plos One
|
August 30, 2021
Impact of HLA type, age and chronic viral infection on peripheral T-cell receptor sharing between unrelated individuals
Sarah A Johnson, Spencer L Seale, Rachel M Gittelman, et al.
Cell Stem Cell
|
November 4, 2017
TGF-β-Induced Quiescence Mediates Chemoresistance of Tumor-Propagating Cells in Squamous Cell Carcinoma
Jessie A Brown, Yoshiya Yonekubo, Nicole Hanson, et al.
JCI Insight
|
July 13, 2018
T cell receptor repertoire features associated with survival in immunotherapy-treated pancreatic ductal adenocarcinoma
Alexander C Hopkins, Mark Yarchoan, Jennifer N Durham, et al.
Journal for Immunotherapy of Cancer
|
October 2, 2020
CDK4/6 inhibition enhances antitumor efficacy of chemotherapy and immune checkpoint inhibitor combinations in preclinical models and enhances T-cell activation in patients with SCLC receiving chemotherapy
Anne Y Lai, Jessica A Sorrentino, Konstantin H Dragnev, et al.
Journal for Immunotherapy of Cancer
|
October 25, 2018
Neoadjuvant ipilimumab (3 mg/kg or 10 mg/kg) and high dose IFN-α2b in locally/regionally advanced melanoma: safety, efficacy and impact on T-cell repertoire
Ahmad Tarhini, Yan Lin, Huang Lin, et al.
Page
of 2